Speaker Profile
Ph.D., Professor, Department of Anesthesia, UCSF
Biography
Dr. Liu is globally recognized for his research in antibody-based cancer therapeutics. He is a professor at University of California, San Francisco and the principle investigator at the Helen Diller Family Comprehensive Cancer Center at UCSF. His discovery of a unique approach to treating prostate cancer and multiple myeloma led to the creation in 2016 of biopharmaceutical company Fortis Therapeutics. Dr. Liu is highly involved in the national cancer therapeutics community, serving as a member of the UCSF Stephen and Nancy Grand Multiple Myeloma Translational Initiative, the Sean Parker Institute for Cancer Immunotherapy and other organizations. He holds a B.A. in Molecular Biology and Biochemical Sciences from Princeton University and a doctorate in Biochemistry and Biophysics from UCSF. He is the recipient of more than a dozen scientific honors and has authored more than 20 articles in peer-reviewed journals.
Session Abstract – PMWC 2025 Silicon Valley
Track Chair: Maggie Chapman, Labcorp
- Cross-Application of Oncology Drugs in Rare Diseases
- Razelle Kurzrock, Medical College of Wisconsin
- PMWC 2025 Award Ceremony
Luminary Honoree: David R. Liu, Broad Institute & Crystal Mackal, Stanford University
Pioneer Honoree: Drew Weissman, Penn Medicine
- Keynote: Base Editing, Prime Editing, and Targeted Gene Integration: Precision Therapeutic Genome Editingn
- David R. Liu, Broad Institute
- Breakthroughs in Cancer Immunotherapy: mRNA Vaccines and CAR T-Cell Advances (PANEL)
Chair: Rick Klausner, Altos Labs
- Drew Weissman, Penn Medicine
- Ira Mellman, Formelly with Genentech
- Crystal Mackal, Stanford University - Next-Generation ADCs: Challenges and Innovations in Immunotherapy Combinations (PANEL)
Chair: Sandhya Girish, Gilead
- Bin Liu, UCSF
- Strategic IP Management in Cell and Gene Therapy: Navigating Legal and Practical Challenges
- Janet Xiao, Morrison & Foerster LLP
- Advances in Allogeneic Cell Therapies: Overcoming Hurdles and Expanding Applications (PANEL)
Chair: Elliot Norry, Adaptimmune
- Larry Lamb, IN8bio
- Indu Ramachandran, Century Therapeutics - Transforming Cancer Treatment: Stem Cell and Gene Therapy Breakthroughs
Chair: Catriona Jamieson, UCSD Health
- Irv Weisman, Stanford
- Advancements and Future Directions in Therapeutic Ultrasound for Precision Medicine
Chair: Masha Stromme, EXACT Therapeutics
- Bradford Elmer, Sanofi
- John de Groot, UCSF
- Raag Airan, Stanford
